Related Experiment Video
Updated: Aug 22, 2026

Visualization of Inflammatory Caspases Induced Proximity in Human Monocyte-Derived Macrophages
Published on: April 6, 2022
INCA, a novel human caspase recruitment domain protein that inhibits interleukin-1beta generation
Mohamed Lamkanfi1, Geertrui Denecker, Michael Kalai
1Unit of Molecular Signalling and Cell Death, Department for Molecular Biomedical Research, VIB-Ghent University, Technologiepark 927, Zwijnaarde B-9052, Belgium.
Insights
Researchers discovered Inhibitory CARD (INCA), a novel protein regulating caspase-1 activation. INCA interacts with procaspase-1, blocking IL-1beta release and inflammation, offering new therapeutic targets.
Area of Science:
- Molecular Biology
- Immunology
- Genetics
Background:
- Caspase recruitment domain (CARD) proteins are crucial in inflammatory pathways.
- Previous studies identified CARD proteins like COP/Pseudo-ICE and ICEBERG, derived from caspase-1 gene duplications.
Purpose of the Study:
- To identify novel CARD proteins involved in caspase-1 regulation.
- To characterize the function and interactions of the newly identified INCA protein.
Main Methods:
- In silico screening of the human genome for CARD proteins.
- Gene expression analysis (mRNA) in various tissues and cell lines.
- Protein-protein interaction studies (co-immunoprecipitation).
- Functional assays measuring IL-1beta release and NF-kappaB activation.
Main Results:
- Identified Inhibitory CARD (INCA) protein, sharing high homology with caspase-1 prodomain.
- INCA mRNA is widely expressed and upregulated by interferon-gamma in monocytic cells.
- INCA physically interacts with procaspase-1, inhibiting mature IL-1beta release from macrophages.
- INCA does not interact with RIP2 or induce NF-kappaB activation, distinguishing it from other CARD proteins.
Conclusions:
- INCA is a novel intracellular regulator of procaspase-1 activation.
- INCA plays a significant role in modulating pro-IL-1beta processing and release during inflammatory responses.
- INCA represents a potential target for controlling inflammatory conditions.
Abstract:
Using in silico methods for screening the human genome for new caspase recruitment domain (CARD) proteins, we have identified INCA (Inhibitory CARD) as a protein that shares 81% identity with the prodomain of caspase-1. The INCA gene is located on chromosome 11q22 between the genes of COP/Pseudo-ICE and ICEBERG, two other CARD proteins that arose from caspase-1 gene duplications. We show that INCA mRNA is expressed in many tissues. INCA is specifically upregulated by interferon-gamma in the monocytic cell lines THP-1 and U937. INCA physically interacts with procaspase-1 and blocks the release of mature IL-1beta from LPS-stimulated macrophages. Unlike COP/Pseudo-ICE and procaspase-1, INCA does not interact with RIP2 and does not induce NF-kappaB activation. Our data show that INCA is a novel intracellular regulator of procaspase-1 activation, involved in the regulation of pro-IL-1beta processing and its release during inflammation.
Related Concept Videos
Caspases
Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
The JAK-STAT Signaling Pathway
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway

